Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Accumulated Expenses (2020 - 2021)

Historic Accumulated Expenses for Ensysce Biosciences (ENSC) over the last 2 years, with Q2 2021 value amounting to $411941.0.

  • Ensysce Biosciences' Accumulated Expenses changed N/A to $411941.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $411941.0, marking a year-over-year change of. This contributed to the annual value of $344792.0 for FY2020, which is N/A changed from last year.
  • Ensysce Biosciences' Accumulated Expenses amounted to $411941.0 in Q2 2021.
  • In the past 5 years, Ensysce Biosciences' Accumulated Expenses registered a high of $411941.0 during Q2 2021, and its lowest value of $344792.0 during Q4 2020.